189 related articles for article (PubMed ID: 7948733)
1. Theoretical conformational analysis of the opioid delta antagonist H-Tyr-Tic-Phe-OH and the mu agonist H-Tyr-D-Tic-Phe-NH2.
Wilkes BC; Schiller PW
Biopolymers; 1994 Sep; 34(9):1213-9. PubMed ID: 7948733
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of various proposed models of the receptor-bound conformation of H-Tyr-Tic-Phe-OH related delta-opioid antagonists.
Wilkes BC; Schiller PW
Biopolymers; 1995; 37(6):391-400. PubMed ID: 8589244
[TBL] [Abstract][Full Text] [Related]
3. The receptor-bound conformation of H-Tyr-Tic-(Phe-Phe)-OH-related delta-opioid antagonists contains all trans peptide bonds.
Wilkes BC; Nguyen TM; Weltrowska G; Carpenter KA; Lemieux C; Chung NN; Schiller PW
J Pept Res; 1998 May; 51(5):386-94. PubMed ID: 9606018
[TBL] [Abstract][Full Text] [Related]
4. Conformation-activity relationships of cyclic dermorphin analogues.
Wilkes BC; Schiller PW
Biopolymers; 1990 Jan; 29(1):89-95. PubMed ID: 2158362
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the bioactive form of linear peptide antagonists at the omega-opioid receptor.
Chao TM; Perez JJ; Loew GH
Biopolymers; 1996 Jun; 38(6):759-68. PubMed ID: 8652796
[TBL] [Abstract][Full Text] [Related]
6. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
[TBL] [Abstract][Full Text] [Related]
7. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
[TBL] [Abstract][Full Text] [Related]
8. Opioid diketopiperazines: refinement of the delta opioid antagonist pharmacophore.
Bryant SD; Balboni G; Guerrini R; Salvadori S; Tomatis R; Lazarus LH
Biol Chem; 1997 Feb; 378(2):107-14. PubMed ID: 9088539
[TBL] [Abstract][Full Text] [Related]
9. N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.
Weltrowska G; Nguyen TM; Chung NN; Wilkes BC; Schiller PW
Bioorg Med Chem Lett; 2013 Sep; 23(18):5082-5. PubMed ID: 23932788
[TBL] [Abstract][Full Text] [Related]
10. Conformational restriction of the phenylalanine residue in a cyclic opioid peptide analogue: effects on receptor selectivity and stereospecificity.
Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Marsden BJ; Wilkes BC
J Med Chem; 1991 Oct; 34(10):3125-32. PubMed ID: 1656045
[TBL] [Abstract][Full Text] [Related]
11. X-ray structure of Tyr-D-Tic-Phe-Phe-NH2 (D-TIPP-NH2), a highly potent mu-receptor selective opioid agonist. Comparison with proposed model structures.
Flippen-Anderson JL; Deschamps JR; George C; Reddy PA; Lewin AH; Brine GA; Sheldrick G; Nikiforovich G
J Pept Res; 1997 May; 49(5):384-93. PubMed ID: 9211219
[TBL] [Abstract][Full Text] [Related]
12. [Aladan3]TIPP: a fluorescent delta-opioid antagonist with high delta-receptor binding affinity and delta selectivity.
Chen H; Chung NN; Lemieux C; Zelent B; Vanderkooi JM; Gryczynski I; Wilkes BC; Schiller PW
Biopolymers; 2005; 80(2-3):325-31. PubMed ID: 15614807
[TBL] [Abstract][Full Text] [Related]
13. Development of a model for the delta-opioid receptor pharmacophore: 3. Comparison of the cyclic tetrapeptide, Tyr-c[D-Cys-Phe-D-Pen]OH with other conformationally constrained delta-receptor selective ligands.
Lomize AL; Pogozheva ID; Mosberg HI
Biopolymers; 1996 Feb; 38(2):221-34. PubMed ID: 8589255
[TBL] [Abstract][Full Text] [Related]
14. Role of hydrophobic substituents in the interaction of opioid Tyr-Tic dipeptide analogs with dodecylphosphocholine micelles. Molecular partitioning in model membrane systems.
Carpenter KA; Wilkes BC; Weltrowska G; Schiller PW
Eur J Biochem; 1996 Nov; 241(3):756-64. PubMed ID: 8944763
[TBL] [Abstract][Full Text] [Related]
15. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
[TBL] [Abstract][Full Text] [Related]
16. Bioactivity of new mu and delta opioid peptides.
Capasso A
Med Chem; 2007 Sep; 3(5):480-7. PubMed ID: 17897075
[TBL] [Abstract][Full Text] [Related]
17. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
Mosberg HI; Lomize AL; Wang C; Kroona H; Heyl DL; Sobczyk-Kojiro K; Ma W; Mousigian C; Porreca F
J Med Chem; 1994 Dec; 37(25):4371-83. PubMed ID: 7996549
[TBL] [Abstract][Full Text] [Related]
18. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
Tourwé D; Mannekens E; Diem TN; Verheyden P; Jaspers H; Tóth G; Péter A; Kertész I; Török G; Chung NN; Schiller PW
J Med Chem; 1998 Dec; 41(26):5167-76. PubMed ID: 9857087
[TBL] [Abstract][Full Text] [Related]
19. Selective opioid dipeptides.
Temussi PA; Salvadori S; Amodeo P; Bianchi C; Guerrini R; Tomatis R; Lazarus LH; Picone D; Tancredi T
Biochem Biophys Res Commun; 1994 Feb; 198(3):933-9. PubMed ID: 8117299
[TBL] [Abstract][Full Text] [Related]
20. Conformational analysis of potent and very selective delta opioid dipeptide antagonists.
Amodeo P; Balboni G; Crescenzi O; Guerrini R; Picone D; Salvadori S; Tancredi T; Temussi PA
FEBS Lett; 1995 Dec; 377(3):363-7. PubMed ID: 8549756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
